Immune thrombocytopenia

Overview

Board takeaway: Dental planning depends on bleeding symptoms, platelet trend, treatment response, and the procedure—not the count alone.

Immune-mediated platelet destruction and impaired platelet production can cause mucocutaneous bleeding. Many children recover, but chronic disease occurs.

How does Immune thrombocytopenia affect dental management?

• Before invasive care: Hematology consult and current platelet count before any invasive care
• Local anesthesia: Agree on hemostatic support before a deep inferior alveolar nerve block when thrombocytopenia or bleeding risk is significant; a low count does not automatically mean platelet transfusion.
• Hemostasis: Atraumatic technique, local hemostatics, sutures, tranexamic acid
• Pain control: acetaminophen is preferred; avoid aspirin and NSAIDs.
• Steroid history: review recent and prolonged courses. Ask about established or suspected adrenal suppression before stressful treatment; steroid exposure alone does not establish a stress-dose regimen.

Loading diagram…

Active mucosal bleeding or hemorrhagic bullae warrants prompt assessment. An elective extraction requires current platelet trend, bleeding history, and a hematology-directed procedural plan; transfusion is not automatic.

Exam pearl

What is Immune thrombocytopenia?

An autoimmune bleeding disorder in which immune-mediated platelet destruction lowers the platelet count, causing easy bruising, petechiae, or mucosal bleeding.

What are the main systemic features of Immune thrombocytopenia?

• Platelets: Antiplatelet antibodies; isolated thrombocytopenia under 100,000/mm³ with otherwise normal blood counts
• Typical course: Peak age 2–5 years, often after a viral infection; about 80% of children recover within 6–12 months
• Bleeding pattern: Petechiae, purpura, epistaxis; wet purpura (mucosal bleeding) signals higher bleeding risk
• Treatment: Treated with observation, corticosteroids, IVIG, anti-D, rituximab or thrombopoietin receptor agonists

What oral findings occur in Immune thrombocytopenia?

• Petechiae and bruising: Petechiae and ecchymoses on palate, buccal mucosa and tongue
• Wet purpura: Hemorrhagic bullae (wet purpura), which signal higher bleeding risk than skin petechiae alone
• Gingival bleeding: Spontaneous gingival bleeding can occur with severe thrombocytopenia; clinical bleeding is not determined by a single universal platelet cutoff

For Immune thrombocytopenia, what is needed before an extraction?

Before the procedure

• Establish risk: a current platelet count/trend, bleeding history, and written hematology plan for the specific extraction and anesthetic injection.
• Agree on support: agree on any platelet-raising treatment, local hemostatics, antifibrinolytic therapy, and the appropriate setting.
• Treatment options: hematology may use corticosteroids, intravenous immunoglobulin, or other ITP treatment when support is needed.

Limits and discharge

• Transfusion: platelet transfusion is not an automatic response to a low count in ITP; its benefit can be transient and its use depends on urgency and bleeding.
• Before discharge: confirm hemostasis before discharge and provide clear instructions for persistent or delayed bleeding.
• Thresholds: oncology platelet thresholds should not be imported as automatic ITP clearance rules.

Sources

• Supplemental systemic features: NHLBI: Immune thrombocytopenia
• Supplemental study guide: Pediatric Dental Study Guide: Idiopathic Thrombocytopenic Purpura [ITP/TTP]
• Common Laboratory Values
• Hematology Consultation for Pediatric Dental Patients